View in EDS

Health impacts of bus rapid transit systems in seven cities worldwide.

Saved in:
Bibliographic Details
Title: Health impacts of bus rapid transit systems in seven cities worldwide.
Authors: Rojas-Rueda, David1,2 (AUTHOR) David.Rojas@colostate.edu, Aramouni, Georgette A.3 (AUTHOR)
Source: Environmental Research. Aug2026:Part 2, Vol. 303, pN.PAG-N.PAG. 1p.
Subjects: Bus rapid transit, Mortality, Health impact assessment, Physical activity, Air pollution, Value (Economics), Public health, Urban transportation
Geographic Terms: Mexico City (Mexico), Bogotá (Colombia)
Abstract: Bus rapid transit (BRT) systems serve over 34 million daily passengers in 180 cities worldwide, yet their population health impacts have not been quantified across cities using standardized methods. We estimated mortality impacts and economic value of BRT in seven cities across four continents (Bogota, Brisbane, Helsinki, Istanbul, Mexico City, Miami, Paris) using comparative risk assessment with probabilistic uncertainty analysis. We assessed all-cause mortality changes from three pathways (physical activity, PM 2.5 inhalation, traffic crashes) applying the WHO HRAPIE-2 endorsed Orellano et al. (2024) PM 2.5 dose-response function. Four car-to-BRT substitution scenarios were evaluated using Monte Carlo simulation (10,000 Latin Hypercube iterations per scenario, six sampled parameters). Economic impacts used country-specific values of a statistical life. Under the current observed substitution, BRT prevented a median of 160 deaths per year (95% UI: −30 to 374), valued at USD 176 million (95% UI: 36 to 477 million). Under complete substitution, 1795 deaths were prevented (95% UI: 432 to 4355) valued at USD 1665 million. Per-city rates ranged from 0.02 to 0.75 deaths prevented per 100,000 metropolitan residents per year under current substitution. Physical activity gains drove the majority of net benefits, partially offset by increased PM 2.5 inhalation during walking. Bogota and Mexico City contributed about 80% of total deaths prevented. Cities investing in BRT should pair infrastructure with measures that maximize car-to-BRT substitution and reduce in-corridor PM 2.5 exposure, the two levers that determine whether modal shift translates into population-level mortality reduction. • First multi-city BRT health impact assessment with Monte Carlo uncertainty. • BRT prevents 160 deaths/year across seven cities (95% UI: −30 to 374, where negative values denote net harm). • Per-100,000 rates range 0.02 to 0.75 deaths prevented annually by city. • Physical activity gains drive net benefits; PM 2.5 inhalation offsets them. • Economic value: USD 176 million (95% UI: 36 to 477) at current substitution. [ABSTRACT FROM AUTHOR]
Copyright of Environmental Research is the property of Academic Press Inc. and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Engineering Source
Description
Abstract:Bus rapid transit (BRT) systems serve over 34 million daily passengers in 180 cities worldwide, yet their population health impacts have not been quantified across cities using standardized methods. We estimated mortality impacts and economic value of BRT in seven cities across four continents (Bogota, Brisbane, Helsinki, Istanbul, Mexico City, Miami, Paris) using comparative risk assessment with probabilistic uncertainty analysis. We assessed all-cause mortality changes from three pathways (physical activity, PM 2.5 inhalation, traffic crashes) applying the WHO HRAPIE-2 endorsed Orellano et al. (2024) PM 2.5 dose-response function. Four car-to-BRT substitution scenarios were evaluated using Monte Carlo simulation (10,000 Latin Hypercube iterations per scenario, six sampled parameters). Economic impacts used country-specific values of a statistical life. Under the current observed substitution, BRT prevented a median of 160 deaths per year (95% UI: −30 to 374), valued at USD 176 million (95% UI: 36 to 477 million). Under complete substitution, 1795 deaths were prevented (95% UI: 432 to 4355) valued at USD 1665 million. Per-city rates ranged from 0.02 to 0.75 deaths prevented per 100,000 metropolitan residents per year under current substitution. Physical activity gains drove the majority of net benefits, partially offset by increased PM 2.5 inhalation during walking. Bogota and Mexico City contributed about 80% of total deaths prevented. Cities investing in BRT should pair infrastructure with measures that maximize car-to-BRT substitution and reduce in-corridor PM 2.5 exposure, the two levers that determine whether modal shift translates into population-level mortality reduction. • First multi-city BRT health impact assessment with Monte Carlo uncertainty. • BRT prevents 160 deaths/year across seven cities (95% UI: −30 to 374, where negative values denote net harm). • Per-100,000 rates range 0.02 to 0.75 deaths prevented annually by city. • Physical activity gains drive net benefits; PM 2.5 inhalation offsets them. • Economic value: USD 176 million (95% UI: 36 to 477) at current substitution. [ABSTRACT FROM AUTHOR]
ISSN:00139351
DOI:10.1016/j.envres.2026.124795